Literature DB >> 25651953

The EPOS-CC Score: An Integration of Independent, Tumor- and Patient-Associated Risk Factors to Predict 5-years Overall Survival Following Colorectal Cancer Surgery.

Yoshio Haga1, Koji Ikejiri, Yasuo Wada, Masakazu Ikenaga, Shoichiro Koike, Seiji Nakamura, Masato Koseki.   

Abstract

BACKGROUND: Surgical audit is an essential task for the estimation of postoperative outcome and comparison of quality of care. Previous studies on surgical audits focused on short-term outcomes, such as postoperative mortality. We propose a surgical audit evaluating long-term outcome following colorectal cancer surgery. The predictive model for this audit is designated as 'Estimation of Postoperative Overall Survival for Colorectal Cancer (EPOS-CC)'.
METHODS: Thirty-one tumor-related and physiological variables were prospectively collected in 889 patients undergoing elective resection for colorectal cancer between April 2005 and April 2007 in 16 Japanese hospitals. Postoperative overall survival was assessed over a 5-years period. The EPOS-CC score was established by selecting significant variables in a uni- and multivariate analysis and allocating a risk-adjusted multiplication factor to each variable using Cox regression analysis. For validation, the EPOS-CC score was compared to the predictive power of UICC stage. Inter-hospital variability of the observed-to-estimated 5-years survival was assessed to estimate quality of care.
RESULTS: Among the 889 patients, 804 (90%) completed the 5-years follow-up. Univariate analysis displayed a significant correlation with 5-years survival for 14 physiological and nine tumor-related variables (p < 0.005). Highly significant p-values below 0.0001 were found for age, ASA score, severe pulmonary disease, respiratory history, performance status, hypoalbuminemia, alteration of hemoglobin, serum sodium level, and for all histological variables except tumor location. Age, TNM stage, lymphatic invasion, performance status, and serum sodium level were independent variables in the multivariate analysis and were entered the EPOS-CC model for the prediction of survival. Risk-adjusted multiplication factors between 1.5 (distant metastasis) and 0.16 (serum sodium level) were accorded to the different variables. The predictive power of EPOS-CC was superior to the one of UICC stage; area under the curve 0.87, 95% CI 0.85-0.90 for EPOS-CC, and 0.80, 0.76-0.83 for UICC stage, p < 0.001. Quality of care did not differ between hospitals.
CONCLUSIONS: The EPOS-CC score including the independent variables age, performance status, serum sodium level, TNM stage, and lymphatic invasion is superior to the UICC stage in the prediction of 5-years overall survival. This higher accuracy might be explained by the inclusion of physiological factors, thus also taking non-tumor-associated deaths into account. Furthermore, EPOS-CC score may compare quality of care among different institutions. Future studies are necessary to further evaluate this score and help improving the prediction of long-term survival following colorectal cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651953     DOI: 10.1007/s00268-015-2962-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Oncology market research provides a feasible index for standardization of colorectal cancer chemotherapy.

Authors:  Yasuhiro Inoue; Yuji Toiyama; Koji Tanaka; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Jpn J Clin Oncol       Date:  2011-09-22       Impact factor: 3.019

2.  Preliminary study of surgical audit for overall survival following gastric cancer resection.

Authors:  Yoshio Haga; Koji Ikejiri; Yasuo Wada; Masakazu Ikenaga; Hitoshi Takeuchi
Journal:  Gastric Cancer       Date:  2014-02-06       Impact factor: 7.370

3.  Value of general surgical risk models for predicting postoperative morbidity and mortality in pancreatic resections for pancreatobiliary carcinomas.

Authors:  Yoshio Haga; Yasuo Wada; Toshihiro Saitoh; Hitoshi Takeuchi; Koji Ikejiri; Masakazu Ikenaga
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-03-19       Impact factor: 7.027

4.  Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery.

Authors:  Y Haga; S Ikei; M Ogawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Low preoperative serum albumin in colon cancer: a risk factor for poor outcome.

Authors:  Cheng-Chou Lai; Jeng-Fu You; Chien-Yuh Yeh; Jinn-Shiun Chen; Reiping Tang; Jeng-Yi Wang; Chih-Chien Chin
Journal:  Int J Colorectal Dis       Date:  2010-12-29       Impact factor: 2.571

6.  Factors associated with survival after resection of colorectal adenocarcinoma in 314 patients.

Authors:  J Carlisle; M Swart; E J C Dawe; M Chadwick
Journal:  Br J Anaesth       Date:  2012-01-17       Impact factor: 9.166

7.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  Activities of daily living and quality of life of elderly patients after elective surgery for gastric and colorectal cancers.

Authors:  Takeshi Amemiya; Koji Oda; Masahiko Ando; Takashi Kawamura; Yuichi Kitagawa; Yayoi Okawa; Akihiro Yasui; Hideyuki Ike; Hiroshi Shimada; Kojiro Kuroiwa; Yuji Nimura; Shinji Fukata
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

9.  Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer.

Authors:  Kenneth S H Chok; Wai Lun Law
Journal:  World J Surg       Date:  2007-05-18       Impact factor: 3.352

10.  Successful implementation of the Department of Veterans Affairs' National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study.

Authors:  Shukri F Khuri; William G Henderson; Jennifer Daley; Olga Jonasson; R Scott Jones; Darrell A Campbell; Aaron S Fink; Robert M Mentzer; Leigh Neumayer; Karl Hammermeister; Cecilia Mosca; Nancy Healey
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.